Tetrazolast
Tetrazolast is a HCV inhibitor with the inhibitory activity ranging from 5% to 20%, extracted from patent WO2005030774.
Product Specifications
CAS Number
95104-27-1
UNSPSC
12352005
Target
HCV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Solubility
10 mM in DMSO
Smiles
C1(C2=CC3=CC=CC=C3N4N=NN=C24)=NN=NN1
Molecular Formula
C10H6N8
Molecular Weight
238.21
References & Citations
[1]Thota, et al. Preparation of tetrazoloquinoline derivatives as inhibitors of HCV.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-CEACAM6-Hu-01 96 Tests
Human Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 (CEACAM6) ELISA Kit
Sign In for Pricing
View Details RD-CEACAM6-Hu-02 48 Tests
Human Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 (CEACAM6) ELISA Kit
Sign In for Pricing
View Details 
BNC402885-500 1x 500 µL
CD81 / TAPA-1 (C81/2885R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details